{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-22-000005","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2022-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.145765+00:00","generated_at":"2026-06-27T11:56:11.450870+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Clorox Q2 net sales fall 8%, gross margin drops 1240 bps to 33%, EPS down 72%","bullets":["Net sales $1.7B, down 8% vs prior year; organic sales -8% reflecting 10-point volume decline.","Gross margin 33% vs 45% a year ago, driven by higher manufacturing & logistics and commodity costs.","Diluted EPS $0.56 (down 72%); adjusted EPS $0.66 (down 67%) excluding strategic digital investments.","Health & Wellness segment net sales down 21%; Household +3%, Lifestyle +2%, International flat.","YTD free cash flow $113M vs $478M prior year; capex $109M; company cites ongoing cost pressures."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-22-000005","json":"https://secwatch.observer/filing/0000021076-22-000005.json","markdown":"https://secwatch.observer/filing/0000021076-22-000005.md","text":"https://secwatch.observer/filing/0000021076-22-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107622000005/0000021076-22-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107622000005/clx-20220203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T11:56:11.450870+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}